Exchange: NASDAQ·Updated 07:30 PM EST

ONC Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 05

Estimated EPS

$1.90

Reported EPS

$3.25

Surprise

+70.96%

Estimated Rev

$1.76B

Reported Rev

$1.89B

Surprise

+7.48%

BeOne Medicines expects operating cash flows and existing cash and cash equivalents to fund expenses and planned long-term investments for at least 12 months; approximately $258.8M of bank loans is due within 12 months.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
$3.76
--
--
N/A
Q3 '26
$1.90
$3.25
70.96%
BEAT
Q2 '26
$1.93
$2.05
6.35%
BEAT
Q1 '26
$1.73
$1.96
13.07%
BEAT
Q4 '25
$1.21
$0.60
-50.28%
MISSED

Advertisement|Remove ads.